DOCS:NYE-Doximity Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 29.86

Change

0.00 (0.00)%

Market Cap

USD 5.28B

Volume

1.10M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
VEEV Veeva Systems Inc Class A

-0.53 (-0.28%)

USD 29.06B
SOLV Solventum Corp.

-0.05 (-0.10%)

USD 10.78B
EVH Evolent Health Inc

-1.19 (-5.40%)

USD 2.52B
TDOC Teladoc Inc

-0.61 (-5.89%)

USD 1.70B
PHR Phreesia Inc

+1.12 (+5.53%)

USD 1.16B
WEAV Weave Communications Inc

+0.08 (+0.93%)

USD 0.63B
MPLN MultiPlan Corporation

-0.01 (-2.96%)

USD 0.25B
AMWL American Well Corp

N/A

USD 0.12B
OWLT Owlet Inc

N/A

USD 0.04B
FOXO FOXO Technologies Inc.

-0.01 (-2.01%)

USD 3.08M

ETFs Containing DOCS

EDOC:LSE Global X Telemedicine & D.. 4.78 % 0.00 %

-0.14 (-1.72%)

USD 4.72M
EDOG:LSE Global X Telemedicine & D.. 4.76 % 0.00 %

-0.10 (-1.72%)

USD 0.15M
EDOC Global X Telemedicine & D.. 4.58 % 0.00 %

-0.07 (-1.72%)

USD 0.05B
DDOC:XETRA Global X Telemedicine & D.. 4.58 % 0.00 %

-0.11 (-1.72%)

USD 5.39M
DDOC:F Global X Telemedicine & D.. 4.58 % 0.00 %

N/A

USD 4.76M
EDOC:SW Global X Telemedicine & D.. 4.58 % 0.00 %

-0.11 (-1.72%)

USD 4.69M
JFWD Jacob Forward ETF 4.47 % 0.00 %

-0.10 (-1.72%)

USD 2.68M

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.49% 100% F 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.49% 100% F 64% D
Trailing 12 Months  
Capital Gain -8.24% 70% C- 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.24% 70% C- 18% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -18.81% 50% F 4% F
Dividend Return -18.81% 50% F 4% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.49% 100% F 54% F
Risk Adjusted Return -96.47% 20% F 2% F
Market Capitalization 5.28B 82% B 77% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.